Literature DB >> 22526827

A case of aseptic abscesses syndrome treated with corticosteroids and TNF-alpha blockade.

Tomoyuki Ito1, Naoko Sato, Hajime Yamazaki, Tadashi Koike, Iwao Emura, Takako Saeki.   

Abstract

Aseptic abscesses syndrome (AA) is an emerging clinicopathological entity characterized by visceral sterile collections of mature neutrophils that do not respond to antibiotics but regress quickly when treated with corticosteroids. Although most previous case reports of AA have been restricted to Europe, we present here a Japanese woman with AA showing recurrence of splenic abscesses, ileocolitis, pyoderma gangrenosum, and arthritis. Although both steroid therapy and tumor necrosis factor (TNF)-alpha blockade were effective, relapses remained frequent.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22526827     DOI: 10.1007/s10165-012-0640-y

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  4 in total

1.  Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.

Authors:  Hakim Ben Abdallah; Karsten Fogh; Rikke Bech
Journal:  Int Wound J       Date:  2019-01-03       Impact factor: 3.315

2.  Periodic Fever and Neutrophilic Dermatosis: Is It Sweet's Syndrome?

Authors:  Raheleh Assari; Vahid Ziaee; Nima Parvaneh; Mohammad-Hassan Moradinejad
Journal:  Case Reports Immunol       Date:  2014-12-04

3.  Aseptic abscess syndrome associated with traveler's diarrhea after a trip to Malaysia.

Authors:  Zois Panos; George Giannopoulos; Eymorfia Papangeli; Emmanouil Antalis; Androula Pavli; Aris Spathis; Garyfalia Poulakou; George Dimitriadis; Ioannis Panayiotides; Dimitrios Boumpas; Sotirios Tsiodras
Journal:  IDCases       Date:  2016-09-15

4.  Rapidly Progressing Aseptic Abscesses in a Patient with Ulcerative Colitis.

Authors:  Yoshiharu Yamaguchi; Marie Nakagawa; Shoko Nakagawa; Kazuhiro Nagao; Satoshi Inoue; Tomoya Sugiyama; Shinya Izawa; Yasutaka Hijikata; Masahide Ebi; Yasushi Funaki; Naotaka Ogasawara; Makoto Sasaki; Kunio Kasugai
Journal:  Intern Med       Date:  2020-09-30       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.